Based on the findings of a new study led by the Translational Genomics Research Institute (TGen), part of City of Hope, a coast-to-coast clinical trial is planned that, if successful, could lead to FDA approval of the first ...
May 3, 2022
0
70
Houston Methodist researchers have identified the genetic and molecular fingerprints of different cancer and immune cells in glioblastoma, the deadliest and most common type of brain cancer in adults.
Apr 5, 2022
0
39
For some types of cancer, the human body itself complicates adequate treatment. Connective tissue and the immune system then build a sort of "defensive wall" around the tumor, through which chemotherapy drugs cannot penetrate. ...
Mar 11, 2022
0
11
Glioblastoma is an aggressive cancer that can occur in the brain or spinal cord. It can occur at any age, but glioblastoma is more common in older adults. The average age of diagnosis is 64.
Mar 8, 2022
0
10
A circular peptide derived from violets could lead to new approaches in treating glioblastoma, a highly aggressive form of brain cancer.
Jan 26, 2022
0
5
Glioblastoma, an aggressive cancer in the brain or spinal cord, has proven stubbornly resistant to newer immunotherapies. And radiation and chemotherapy, the standard treatment for glioblastoma, result in fewer than 10 percent ...
Jan 19, 2022
0
133
Researchers at the University of Sussex are one step further to developing a blood test capable of diagnosing the most aggressive form of brain tumor.
Jan 17, 2022
0
97
Inhaled CBD shrinks the size of the highly aggressive, lethal brain tumor glioblastoma in an animal model by reducing the essential support of its microenvironment, researchers report.
Dec 23, 2021
0
426
Glioblastoma is widely considered the most aggressive brain cancer. Even with treatment, patient survival rates are low, with most living an average of 15–18 months after diagnosis. Because of the highly diverse characteristics ...
Dec 21, 2021
0
81
Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas—the most common and malignant of primary brain tumors—might benefit from immunotherapy.
Nov 29, 2021
0
73
